Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Lewis, Victoria ^a,b   Whitehouse, Isobel J ^a   Baybutt, Herbert ^c   Manson, Jean C ^c   Collins, Steven J ^b   Hooper, Nigel M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; PRION PROTEIN; APP PROTEIN, HUMAN; ISOPROTEIN; MUTANT PROTEIN; SECRETASE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; TRANSGENE; ANIMAL; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; PRION; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL LINE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MICE; MUTANT PROTEINS; PRIONS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84857398743     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031754     Document Type: Article

References (37)

1. Wisniewski T, Sigurdsson EM, (2007) Therapeutic approaches for prion and Alzheimer's diseases. FEBS J 274: 3784-3798.
2. Checler F, Vincent B, (2002) Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 25: 616-620.
3. Taylor DR, Hooper NM, (2007) Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins. Semin Cell Dev Biol 18: 638-648.
4. Barnham KJ, Cappai R, Beyreuther K, Masters CL, Hill AF, (2006) Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem Sci 31: 465-472.
5. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, et al. (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci USA 104: 11062-11067.
6. Griffiths HH, Whitehouse IJ, Baybutt H, Brown D, Kellett KA, et al. (2011) Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein. J Biol Chem 286: 33489-33500.
7. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM, (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457: 1128-1132.
8. Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, et al. (2010) Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci USA 107: 2295-2300.
9. Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, et al. (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med 2: 306-314.
10. Chen S, Yadav SP, Surewicz WK, (2010) Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues. J Biol Chem 285: 26377-26383.
11. Barry AE, Klyubin I, McDonald JM, Mably AJ, Farrell MA, et al. (2011) Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci 31: 7259-7263.
12. Freir DB, Nicoll AJ, Klyubin I, Panico S, McDonald JM, et al. (2011) Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites. Nat Commun 2: 336.
13. Vardy ER, Catto AJ, Hooper NM, (2005) Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease. Trends Mol Med 11: 464-472.
14. Cao X, Sudhof TC, (2001) A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293: 115-120.
15. Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ, (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep 10: 94-100.
16. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, et al. (2005) Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46: 541-554.
17. Goodger ZV, Rajendran L, Trutzel A, Kohli BM, Nitsch RM, et al. (2009) Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci 122: 3703-3714.
18. Hoey SE, Williams RJ, Perkinton MS, (2009) Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci 29: 4442-4460.
19. Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, et al. (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a beta-secretase-dependent pathway. J Biol Chem 285: 41443-41454.
20. Tanaka S, Nakamura S, Ueda K, Kameyama M, Shiojiri S, et al. (1988) Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease. Biochem Biophys Res Commun 157: 472-479.
21. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, et al. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360: 672-674.
22. Vincent B, Sunyach C, Orzechowski HD, St George-Hyslop P, Checler F, (2009) p53-Dependent transcriptional control of cellular prion by presenilins. J Neurosci 29: 6752-6760.
23. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, et al. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20: 4050-4058.
24. Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, et al. (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 96: 116-122.
25. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, et al. (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513-529.
26. Tsuchiya K, Yagishita S, Ikeda K, Sano M, Taki K, et al. (2004) Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD. Neuropathology 24: 46-55.
27. Takahashi RH, Tobiume M, Sato Y, Sata T, Gouras GK, et al. (2010) Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain. Neuropathology 3: 2080214.
28. Voigtlander T, Kloppel S, Birner P, Jarius C, Flicker H, et al. (2001) Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta neuropathologica 101: 417-423.
29. Deslys JP, Marce D, Dormont D, (1994) Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 75: 23-27.
30. Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, et al. (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98: 259-264.
31. Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, et al. (2004) Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 63: 364-366.
32. Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, et al. (2006) Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging 27: 770 e1-770 e5.
33. Gacia M, Safranow K, Styczynska M, Jakubowska K, Peplonska B, et al. (2006) Prion protein gene M129 allele is a risk factor for Alzheimer's disease. J Neural Transm 113: 1747-1751.
34. Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, et al. (2010) Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 30: 4528-4535.
35. Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, et al. (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30: 6367-6374.
36. Kellett KA, Hooper NM, (2009) Prion protein and Alzheimer disease. Prion 3: 190-194.
37. Nishida N, Harris DA, Vilette D, Laude H, Frobert Y, et al. (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol 74: 320-5.